These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38026594)

  • 1. Non-Invasive Treatment of Early Diabetic Macular Edema by Multiwavelength Photobiomodulation with the Valeda Light Delivery System.
    Kaymak H; Munk MR; Tedford SE; Croissant CL; Tedford CE; Ruckert R; Schwahn H
    Clin Ophthalmol; 2023; 17():3549-3559. PubMed ID: 38026594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration.
    Burton B; Parodi MB; Jürgens I; Zanlonghi X; Hornan D; Roider J; Lorenz K; Munk MR; Croissant CL; Tedford SE; Walker M; Ruckert R; Tedford CE
    Ophthalmol Ther; 2023 Apr; 12(2):953-968. PubMed ID: 36588113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in Central Serous Chorioretinopathy Following Multiwavelength Photobiomodulation Treatment - Case Report.
    Sachdev A
    Ophthalmol Ther; 2024 Jul; 13(7):2055-2060. PubMed ID: 38758517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical and clinical studies of photobiomodulation therapy for macular oedema.
    Shen W; Teo KYC; Wood JPM; Vaze A; Chidlow G; Ao J; Lee SR; Yam MX; Cornish EE; Fraser-Bell S; Casson RJ; Gillies MC
    Diabetologia; 2020 Sep; 63(9):1900-1915. PubMed ID: 32661752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera Valeda Light Delivery System.
    Boyer D; Hu A; Warrow D; Xavier S; Gonzalez V; Lad E; Rosen RB; Do D; Schneiderman T; Ho A; Munk MR; Jaffe G; Tedford SE; Croissant CL; Walker M; Rückert R; Tedford CE
    Retina; 2024 Mar; 44(3):487-497. PubMed ID: 37972955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION.
    Markowitz SN; Devenyi RG; Munk MR; Croissant CL; Tedford SE; Rückert R; Walker MG; Patino BE; Chen L; Nido M; Tedford CE
    Retina; 2020 Aug; 40(8):1471-1482. PubMed ID: 31404033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of retinal sensitivity, visual acuity and central macular thickness in different types of diabetic macular edema].
    Yang XL; Zou HD; Xu X
    Zhonghua Yan Ke Za Zhi; 2013 Dec; 49(12):1081-8. PubMed ID: 24499694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary observation on rod cell photobiomodulation in treating diabetic macular edema.
    Chen Z; Chen B; Hu P; Liu H; Zheng D
    Adv Ophthalmol Pract Res; 2022; 2(2):100051. PubMed ID: 37846386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept: The AQUA Study.
    Garweg JG; Stefanickova J; Hoyng C; Schmelter T; Niesen T; Sowade O; Sivaprasad S;
    Ophthalmol Retina; 2019 Jul; 3(7):567-575. PubMed ID: 31080168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.
    Lois N; Campbell C; Waugh N; Azuara-Blanco A; Maredza M; Mistry H; McAuley D; Acharya N; Aslam TM; Bailey C; Chong V; Downey L; Eleftheriadis H; Fatum S; George S; Ghanchi F; Groppe M; Hamilton R; Menon G; Saad A; Sivaprasad S; Shiew M; Steel DH; Talks JS; Doherty P; McDowell C; Clarke M
    Health Technol Assess; 2022 Dec; 26(50):1-86. PubMed ID: 36541393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema after Ranibizumab Injections.
    Chang YC; Huang YT; Hsu AY; Meng PP; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Lin JM; Chen WL; Tsai YY
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984630
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantification of Fluid Resolution and Visual Acuity Gain in Patients With Diabetic Macular Edema Using Deep Learning: A Post Hoc Analysis of a Randomized Clinical Trial.
    Roberts PK; Vogl WD; Gerendas BS; Glassman AR; Bogunovic H; Jampol LM; Schmidt-Erfurth UM
    JAMA Ophthalmol; 2020 Sep; 138(9):945-953. PubMed ID: 32722799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal bevacizumab for treatment of diabetic macular edema.
    Seo JW; Park IW
    Korean J Ophthalmol; 2009 Mar; 23(1):17-22. PubMed ID: 19337474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrophy of the central neuroretina in patients treated for diabetic macular edema.
    Karst SG; Schuster M; Mitsch C; Meyer EL; Kundi M; Scholda C; Schmidt-Erfurth UM
    Acta Ophthalmol; 2019 Dec; 97(8):e1054-e1061. PubMed ID: 31228332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective, Observational, Multicenter, Real-World Study of the Efficacy, Safety, and Pattern of Use of the Dexamethasone Intravitreal Implant in Diabetic Macular Edema in France: Short-Term Outcomes of LOUVRE 3.
    Kodjikian L; Delcourt C; Creuzot-Garcher C; Massin P; Conrath J; Velard MÈ; Lassalle T; Pinchinat S; Dupont-Benjamin L
    Ophthalmol Ther; 2023 Jun; 12(3):1671-1692. PubMed ID: 36967448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifocal electroretinography changes at the 1-year follow-up in a cohort of diabetic macular edema patients treated with ranibizumab.
    Baget-Bernaldiz M; Romero-Aroca P; Bautista-Perez A; Mercado J
    Doc Ophthalmol; 2017 Oct; 135(2):85-96. PubMed ID: 28779336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment response to Conbercept of different types of diabetic macular edema classified based on optical coherence tomography].
    Zhang Y; Yao J; Quan Y; Wang J; Xing Y; Zhou A
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1501-1508. PubMed ID: 34755665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does HbA1c Level or Glomerular Filtration Rate Affect the Clinical Response to Endothelial Growth Factor Therapy (Ranibizumab or Aflibercept) in Diabetic Macular Edema? A Real-Life Experience.
    Debourdeau E; Medard R; Chamard C; Nguyen V; Gabrielle PH; Creuzot-Garcher C; Allieu S; Gillies MC; Barthelmes D; Daien V;
    Ophthalmol Ther; 2023 Oct; 12(5):2657-2670. PubMed ID: 37505396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravitreal triamcinolone combined with grid laser photocoagulation for patients with cystoid macular edema and advanced diabetic retinopathy: pilot study].
    Arévalo JF; Fernández CF; Mendoza AJ; García RA; Arévalo FA
    Arch Soc Esp Oftalmol; 2013 Oct; 88(10):373-9. PubMed ID: 24060300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
    Luís ME; Sampaio F; Costa J; Cabral D; Teixeira C; Ferreira JT
    Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.